BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Signaling Lymphocytic Activation Molecule Family

the surface of CD4 or CD8-positive T-CELLS; NATURAL KILLER CELLS; and some populations of B CELLS. They are characterized by an N-terminal, extracellular IMMUNOGLOBULIN-LIKE DOMAIN and a membrane-proximal IMMUNOGLOBULIN C2-SET DOMAIN. SLAMF receptors typically signal through homophilic interactions and are important for mediating the immune response and immune cell differentiation.

102+ PubMed studies analyzed · Evidence Score: 44.9

Research Domains

Signaling Lymphocytic Activation Molecule Family has been studied across 19 research domains including 🛡️ Immunity, 🔬 Oncology, 🔬 Inflammation, 🦴 Bone & Joint, ⏳ Longevity & Aging. The primary research focus is 🛡️ Immunity with 33% of studies addressing this area.

Loading evidence profile...

This evidence profile for Signaling Lymphocytic Activation Molecule Family is generated deterministically from 102 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.